Caba stock forecast 2025 long-term investors reviewing "CABA

Long-term investors reviewing "CABA stock forecast 2025" expect dividend introduction remains unlikely, focusing purely on growth equity valuation. This keeps capital reinvestment into R&D at the forefront of projections. A deeper look at our ownership data shows that the top 25 shareholders collectively hold less than half of the register, suggesting a large group of small holders where no single shareholder has a majority. While these bullish forecasts may appear unrealistic now, some artificial intelligence (AI) stocks have risen by 400% to 600% this year. Furthermore, biotech stocks have the potential to rally sky-high once they have one or a few successful drugs on the market. Positive EPS deviations from consensus could shift the price channel toward $24–26 range in bullish conditions.